Table 1 Summary of input data.
Total individuals sampled | Africa | Americas | Asia | Europe | World |
|---|---|---|---|---|---|
23,349 | 37,410 | 32,971 | 37,457 | 131,187 | |
17.8% | 28.5% | 25.1% | 28.6% | ||
Genotype | 1,720 | 1,107 | 5,993 | 336 | 9,156 |
FY*A/*A | 40 | 183 | 5,805 | 42 | 6,070 |
FY*A/*B | 88 | 341 | 24 | 174 | 627 |
FY*B/*B | 49 | 217 | 6 | 117 | 389 |
FY*A/*A ES | 0 | 0 | 157 | 0 | 157 |
FY*A/*B ES | 226 | 122 | 0 | 0 | 348 |
FY*B/*A ES | 0 | 0 | 0 | 0 | 0 |
FY*B/*B ES | 190 | 122 | 1 | 1 | 314 |
FY*A ES /*A ES | 0 | 0 | 0 | 0 | 0 |
FY*A ES /*B ES | 4 | 0 | 0 | 0 | 4 |
FY*B ES /*B ES | 1,123 | 122 | 0 | 2 | 1,247 |
Phenotype | 11,370 | 10,939 | 11,143 | 17,126 | 50,578 |
Fy(a+b+) | 1,448 | 3,841 | 2,471 | 7,355 | 15,115 |
Fy(a+b−) | 1,338 | 3,904 | 6,821 | 4,872 | 16,935 |
Fy(a−b+) | 2,493 | 2,595 | 1,493 | 4,873 | 11,454 |
Fy(a−b−) | 6,091 | 599 | 358 | 26 | 7,074 |
Promoter | 7,290 | 803 | 187 | 104 | 8,384 |
Fy(+) | 7,266 | 406 | 0 | 0 | 7,672 |
Fy(−) | 24 | 397 | 187 | 104 | 712 |
Phenotype-a | 2,821 | 24,420 | 15,648 | 17,891 | 60,780 |
Fy(a+) | 589 | 19,950 | 12,436 | 11,616 | 44,591 |
Fy(a−) | 2,232 | 4,470 | 3,212 | 6,275 | 16,189 |
Phenotype-b | 148 | 141 | 0 | 2,000 | 2,289 |
Fy(b+) | 1 | 55 | 0 | 1,651 | 1,707 |
Fy(b−) | 147 | 86 | 0 | 349 | 582 |
Total sites | 203 | 265 | 217 | 136 | 821 |
surveyed | 24.7% | 32.3% | 26.4% | 16.6% |
